99results about How to "Improve depression" patented technology

The invention describes methods of treating depression comprising administering a TNFα antibody, such as a human TNFα antibody.

A golf ball includes a spherical outer surface and a plurality of dimples formed thereon. The dimples have an inner land surface with at least one spiral depression either disposed or superimposed on the inner land surface to energize or agitate the airflow over the dimpled surfaces to increase the aerodynamic performance of the golf ball. The spiral depression may turn clockwise or counterclockwise and can be either spaced apart, touching or overlapping each other. While the dimples may be circular, polygonal, triangular or elliptical, dimples having a cross section greater than 0.18 inch are preferred. The dimples may also comprise spiral depressions directly on the spherical surface of the ball.

This invention protects the use of nicotine, analogues thereof precursors thereof or its derivates for treatment of inflammatory, infectious, candidal or degenerative (of the joints and / or of the central nervous system, of kidneys, the lungs, liver), depression, obesity, bone disease and the like, which can be improved by means of intensification of the actions of α-MSH, given the fact that this hormone are extraordinary properties: e.g., it has an antipyretic potency 20,000 times as great as acetaminophen, its antimicrobian potency, is comparable to gentamycine, it is the best anticandidiasic known; it inhibits apoptosis of various stem cells, and significantly modulates the immune reactions, and therefore the use of agents that affect its release may have significant therapeutic potential. This patent protects the use of nicotine, analogues thereof, precursors thereof or its derivates for the purpose of increasing and / or reducing the bioavailability of α-MSH in blood and / or central or peripheral tissues to accentuate or diminish the effect of the α-MSH by means of changes in its concentration or its effect on the corresponding receptors of any cell, tissue or organ in the body, administrated for therapeutic and / or prophylactic purposes in the short medium and / or long term.

The invention relates to a traditional Chinese medicine extract composition for treating gastrointestinal dysfunction or irritable bowel syndrome (IBS), and a preparation method and applications thereof in the preparation of medicaments. The traditional Chinese medicine extract composition comprises the following raw materials: 9-12g of radix bupleuri, 9-12g of paeonia lactiflora, 9-12g of atractylodes macrocephaia, 9-12g of tuckahoe, 3-6g of liquorice, 3-6 gof radix pseudostellariae and 3-6g of rhizoma ligustici wallichii. The invention is characterized in that all the components use extracts of raw medicinal drugs, wherein the volatile oil of atractylodes macrocephaia is component 1; the concentrated extract of water decocted liquid of atractylodes macrocephaia dregs after extracting the volatile oil and other drugs is component 2; and a proper amount of cyclodextrin is component 3. The invention overcomes the traditional viewpoint that the effect of the total extract or water decocted liquid of the traditional Chinese drugs is better than that of the partial extract, and selectively uses the volatile oil of the raw medicinal drugs. Through the combining treatment, the invention obviously improves the preparation performance of the extracts and ensures the quality of the composition. The traditional Chinese medicine extract composition for treating gastrointestinal dysfunction or irritable bowel syndrome (IBS) has unexpected effects by using the extracts.

The uses of nicotine, analogues, precursors or derivatives thereof for treatment of inflammatory, infectious, candidal or degenerative diseases of the joint, central nervous system, kidney, lung, and liver, depression, obesity, bone disease and the like are described. The various diseases, disorders or conditions can be improved by means of intensification of the actions of α-MSH, whose release is affected by the use of nicotine, analogues, precursors or derivatives thereof, which can increase and / or reduce the bioavailability of α-MSH in blood and / or central or peripheral tissues to accentuate or diminish the effect of the α-MSH for therapeutic and / or prophylactic purposes.

The invention discloses a medicine for treating depression, and a preparation method thereof. The medicine is prepared from bupleurum chinense, root of red-rooted salvia, acorus gramineus, thinleaf milkwort rootbark, zedoary, coptis chinensis, dragon bone, oyster, and chlorite schist in a certain weight part proportion; bupleurum chinense, root of red-rooted salvia, acorus gramineus, thinleaf milkwort rootbark, zedoary and coptis chinensis are extracted by a percolation method, dragon bone, oyster, and chlorite schist are extracted by a levigation method, then extracts are mixed, and mixed extracts and auxiliary materials are mixed to be prepared into any common oral formulation. The medicine has the effects of soothing the liver and regulating vital energy, activating blood and dissolving stasis, tranquilizing the mind, reducing phlegm and purging fire and the like, is used for treating liver qi stagnation, vexation and sleeplessness and other symptoms, and is also used for treating depression.

An antidepressant containing, as an active ingredient, at least one compound selected from a branched amino acid, a pharmaceutically acceptable salt thereof and a derivative thereof.

The invention discloses a traditional Chinese medicine composition with functions of treating insomnia, improving senile dementia, enhancing learning and memory abilities, resisting to depression and anxiety and soothing the nerves and benefitting intelligence.The traditional Chinese medicine composition comprises Rhizoma Gastrodiae, Radix Paeoniae Alba, Radix Acanthopanacis Senticosi and Semen Ziziphi Spinosae.The traditional Chinese medicine composition can be prepared into dosage forms acceptable clinically or pharmaceutically.Animal experiments show that the traditional Chinese medicine composition can improve the sleeping function and senile dementia and enhance learning and memory abilities, and has the anti-depression and anti-anxiety effects.

The invention relates to the field of medicines, and particularly relates to a composition capable of regulating mood. The composition is prepared from lactobacillus helveticus R52, bifidobacterium longum R175, fructooligosaccharide, galacto oligosaccharide and xylo-oligosaccharide. The composition capable of regulating the mood provided by the invention has the characteristics of mildness and noside effects, and moreover, negative mood such as anxiety, depression, irritability and restlessness can be regulated, and symptoms of patients suffering from depression and anxiety can be effectivelyimproved.

A pomegranate pulp extract is disclosed. The pomegranate pulp extract is effective in relieving women's menopausal symptoms, anxiety disorders, depression or attention deficit disorders due to the presence of a large amount of ellagic acid. Further disclosed is a method for further improving the relieving effect of the pomegranate extract on women's menopausal symptoms, anxiety disorders, depression or attention deficit disorders. The method includes increasing the content of ellagic acid in the pomegranate extract.

The invention discloses a traditional Chinese medicine composition capable of enhancing memory and relieving depression, a preparation method and applications thereof. The composition is composed of the following raw materials in parts by weight: 2 to 5 parts of ginseng, 1 to 5 parts of polygala root, 1 to 5 parts of acorus tatarinowii, 2 to 5 parts of poria cocos, 1 to 5 parts of dwarf lilyturf tuber, 1 to 5 parts of Chinese magnoliavine, 1 to 5 parts of curcuma tuber, 1 to 5 parts of cape jasmine, and 0.1 to 0.5 part of ginkgo leaf extract. The provided traditional Chinese medicine composition can prevent neurodegeneration dementia, relieve suppression, delay the deterioration of memory, and improve the memory of patients of neurodegeneration dementia, has the advantages of reliable curative effect, good safety, and low happening rate of adverse reaction, and can be used to prepare drugs for preventing neurodegeneration dementia and suppression.

The invention discloses preserving and nourishing milk for females, belonging to the technical field of processing of dairy products. The milk is characterized in that the finished product milk per kg comprises the following components by weight: 200-1000mg of a Saussurea involucrata culture, 600-2400mg of a rose extract (10:1), 2500-15000mg of inulin and 10-20mg of ferrum (Fe). The milk disclosed by the invention has the advantages that the milk not only supplements comprehensive nutrition required by a human body, but also can improve symptoms of females in menstrual period to facilitate human health. According to the preserving and nourishing milk for females, luster, taste, stability and the like are not adversely affected, so that the milk is convenient to eat and carry. The milk normally eaten does not bring harm and toxic and side effects to human body.

The present invention provides a pharmaceutical agent having high safety and a neurotrophic factor-like activity, which contains, as an active ingredient, any one compound included in fatty acids each having 8 carbon atoms (C8) or having 10 carbon atoms (C10) to 12 carbon atoms (C12) or fatty acid esters thereof, such as 3,7-dimethyloctanoic acid ethyl ester, geranic acid ethyl ester, and the like, each of which has 8 carbon atoms (C8), decanoic acid methyl ester, trans-2-decenoic acid, trans-2-decenoic acid methyl ester, trans-2-decenoic acid ethyl ester, trans-2-decenoic acid-2-decenyl ester, trans-2-decenoic acid cyclohexyl ester, trans-2-decenoic acid isopropyl ester, trans-3-decenoic acid methyl ester, trans-9-decenoic acid methyl ester, and the like, each of which has 10 carbon atoms (C10), trans-10-undecenoic acid methyl ester, trans-10-undecenoic acid ethyl ester, and the like, each of which has 11 carbon atoms (C11), and dodecanoic acid, and the like, each of which has 12 carbon atoms (C12), or salts thereof or prodrugs thereof.

An antidepressant containing, as an active ingredient, at least one compound selected from a branched amino acid, a pharmaceutically acceptable salt thereof and a derivative thereof.